|
|
|||||||||
Dr. Ford is Associate Director for Clinical Research, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD.
Dr. Minasian is Chief, Community Oncology and Prevention Trials Research Group and Program Director for the Selenium and Vitamin E Cancer Prevention Trial (SELECT), Division of Cancer Prevention, National Cancer Institute, Bethesda, MD.
Dr. McCaskill-Stevens is Program Director in the Community Oncology and Prevention Trials Research Group and Program Director for the Study of Tamoxifen and Raloxifene (STAR), Division of Cancer Prevention, National Cancer Institute, Bethesda, MD.
Dr. Pisano is Professor, Radiology and Biomedical Engineering, University of North Carolina School of Medicine, Chapel Hill, NC.
Dr. Sullivan is Associate Director, Biomedical Imaging Program/ Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
Dr. Smith is Director, Cancer Screening, Cancer Control Science Department, American Cancer Society, Atlanta, GA.
Enrollment into cancer prevention and early detection clinical trials represents a unique challenge compared with a diagnostic or treatment trial because it involves subjects without a diagnosis of cancer. This paper examines some of the barriers to participation in prevention and early detection trials and provides detailed information about two ongoing prevention and two ongoing early detection clinical trials open to enrollment as well as brief summaries of seven additional trials now open to enrollment.
This article has been cited by other articles:
![]() |
R. A. Smith, V. Cokkinides, and O. W. Brawley Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening CA Cancer J Clin, January 1, 2009; 59(1): 27 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Smith, V. Cokkinides, and O. W. Brawley Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues CA Cancer J Clin, May 1, 2008; 58(3): 161 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Smith, V. Cokkinides, and H. J. Eyre Cancer Screening in the United States, 2007: A Review of Current Guidelines, Practices, and Prospects CA Cancer J Clin, March 1, 2007; 57(2): 90 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lopez-Lazaro Hypoxia-Inducible Factor 1 as a Possible Target for Cancer Chemoprevention Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2332 - 2335. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Goodman, M. D. Thornquist, C. Edelstein, and G. S. Omenn Biorepositories: Let's Not Lose What We Have So Carefully Gathered! Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 599 - 601. [Full Text] [PDF] |
||||
![]() |
J. M. Trauth, J. C. Jernigan, L. A. Siminoff, D. Musa, D. Neal-Ferguson, and J. Weissfeld Factors Affecting Older African American Women's Decisions to Join the PLCO Cancer Screening Trial J. Clin. Oncol., December 1, 2005; 23(34): 8730 - 8738. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Hamilton, T J Peters, A Round, and D Sharp What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study Thorax, December 1, 2005; 60(12): 1059 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Strauss, L. Dominioni, J. R. Jett, M. Freedman, and F. W. Grannis Jr Como International Conference Position Statement: Lung Cancer Screening for Early Diagnosis 5 Years After The 1998 Varese Conference Chest, April 1, 2005; 127(4): 1146 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Smith, V. Cokkinides, and H. J. Eyre American Cancer Society Guidelines for the Early Detection of Cancer, 2005 CA Cancer J Clin, January 1, 2005; 55(1): 31 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Smith, V. Cokkinides, and H. J. Eyre American Cancer Society Guidelines for the Early Detection of Cancer, 2004 CA Cancer J Clin, January 1, 2004; 54(1): 41 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Sabichi, M.-F. Demierre, E. T. Hawk, C. E. Lerman, and S. M. Lippman Frontiers in Cancer Prevention Research Cancer Res., September 15, 2003; 63(18): 5649 - 5655. [Full Text] [PDF] |
||||
![]() |
J. W. Yates Clinicians in Community Practice Are Major Contributors to Clinical Trials in Cancer Prevention, Early Detection, and Treatment CA Cancer J Clin, March 1, 2003; 53(2): 69 - 72. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |